Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Immunotherapy
Clinical Trials
Breast Cancer
PARP Inhibitors
Colorectal Cancer
Antibody-Drug Conjugates
Non-Hodgkin Lymphoma
Multiple Myeloma
Ovarian Cancer
Prostate Cancer
Chronic Lymphocytic Leukemia
CAR T-Cell Therapy
Endometrial Cancer
Chemotherapy
Gastroesophageal Cancer
Bispecific Antibodies
BTK Inhibitors
Non-Small Cell Lung Cancer
Follicular Lymphoma
Metastatic Breast Cancer

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes445Founded6 years ago
Number of ListenersCategories
MedicineHealth & FitnessScience

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics:

• Introduction (0:00)

• Overview of Antibody-Drug Conjugates (ADCs)... more

Featuring an interview with Dr Rana R McKay, including the following topics:

• Prostate Cancer Working Group (PCWG4) revised terminology (0:00)

• Cardiovascular effects associated with GnRH agonists versus antagonists; mechanism of action (2:17)

• C... more

YouTube

Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics:

• Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Can... more

YouTube

Featuring perspectives from Dr Lyudmila Bazhenova and Dr Corey J Langer, including the following topics:

• Introduction (0:00)

• Therapeutic Approaches Targeting HER2 and RET — Dr Bazhenova (9:09)

• Therapeutic Approaches Targeting ALK and ROS1 — D... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Joyce O'Shaughnessy
Clinician-researcher discussing case-based insights on HR+, HER2-negative disease
Sarah Cannon Research Institute
Episode: HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
Jane Meisel
Faculty member discussing case and treatment decisions
Winship Cancer Institute of Emory University
Episode: HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
Gus Fonseca
Dr Gus Fonseca, Florida Cancer Specialist Research Institute
Florida Cancer Specialists
Episode: Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
Courtney DiNardo
Dr Courtney DiNardo, University of Texas MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
Harry Erba
Dr Harry Erba, Duke University School of Medicine
Duke University School of Medicine
Episode: Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
Miernal Miernal Gounder
Memorial Sloan Kettering Cancer Center clinician and expert in desmoid tumors
Memorial Sloan Kettering Cancer Center
Episode: Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit
Richard Riedel
Rich Riedel, Duke Cancer Institute
Duke Cancer Institute
Episode: Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit
Chakar Peles
Chakar Peles, Florida Cancer Specialists
Florida Cancer Specialists
Episode: Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit
Kevin Punie
Professor from Zass Hospitals
Zass Hospitals, Antwerp, Belgium
Episode: Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know

Host

Neil Love
Multiple episode host with affiliations to Research To Practice and Oncology Today-related programs; central figure guiding many interviews.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#116
Saudi Arabia/Science
Apple Podcasts
#117
South Korea/Science
Apple Podcasts
#208
Hong Kong/Science

Talking Points

Recent interactions between the hosts and their guests.

Ovarian Cancer — Fifth Annual National General Medical Oncology Summit
Q: What is the current thinking on the duration of PARP inhibitor maintenance in BRCA-mutated ovarian cancer after a response to initial therapy (two years vs one year)?
Most clinicians are leaning toward two years of PARP inhibitor maintenance when feasible, citing MDS/AML risks with longer exposure but also acknowledging some patients do well with shorter durations; ongoing trials may clarify if shorter duration can provide similar efficacy with less toxicity.
Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper
Q: What is the role of gamma-secretase inhibitors like niragacistat/nirogazistat, and how do you sequence or choose between them?
Gamma-secretase inhibitors can yield rapid symptomatic relief and meaningful radiographic responses in a substantial subset of patients; when one inhibitor is used and progresses, a second inhibitor can be tried, though experience is still evolving and data are expanding in the coming years.
Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper
Q: How long do you typically treat with these systemic therapies before deciding to stop or pause?
In many cases therapy is continued for roughly six to twelve months with objective responses; once there is no further regression and disease stabilizes, a pause or tapering is considered, often around one to one-and-a-half years, depending on the individual case.
Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper
Q: Could you tell us about the association of Desmoid tumors during pregnancy and the theories behind it?
There is a known higher incidence in young women during or after pregnancy, suggesting hormonal or estrogen-related influences, but direct proof remains elusive, which is why antihormonal therapies are not routinely recommended.
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress
Q: What is the optimal approach to biomarker assessment for newly diagnosed advanced endometrial cancer?
Biomarker assessment is evolving toward automatic reflex testing for mismatch repair status, with larger emphasis on confirming MMR status via IHC, plus consideration of BRCA-like mutations and other DNA damage response markers; decisions are increasingly guided by institutional workflows and insurance coverage, balancing rapid availability of results with the need for comprehensive profiling.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

Medical oncology-focused conversations feature in-depth interviews and panel discussions with leading cancer researchers and clinicians. Episodes emphasize practical decision-making in biomarker-driven therapy, targeted agents, immunotherapy, and emerging diagnostic technologies, often anchored by real patient cases and community oncologist perspectives. Across samples, themes include PARP inhibitors in prostate cancer, ctDNA/MRD-guided colorectal cancer strategies, and the integration of novel agents (e.g., CELMoDs, antibody-drug conjugates) into front-line and relapse settings. Notable is the strong emphasis on translating trial data into everyday practice, including testing strategies, sequencing decisions, toxicity management, and the e... more

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Two Onc Docs
2. ASCO Daily News
3. Research To Practice | Oncology Videos
4. Oncology Brothers: Practice-Changing Cancer Discussions
5. Breast Cancer Update

How many episodes of Oncology Today are there?

Oncology Today launched 6 years ago and published 445 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Joyce O'Shaughnessy
2. Jane Meisel
3. Gus Fonseca
4. Courtney DiNardo
5. Harry Erba
6. Miernal Miernal Gounder
7. Richard Riedel
8. Chakar Peles

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days